These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8009599)

  • 1. Lymphoid organ production of immunomodulatory eicosanoids in mice resistant to neonatal tolerance induction.
    Nassiri M; Viciana A; Padmanabhan J; Streilein JW; Ruiz P
    Transplantation; 1994 Jun; 57(11):1643-52. PubMed ID: 8009599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of donor chimerism, alloreactive host T cells and memory cell development in thymi from mice resistant to neonatal transplantation tolerance.
    Ruiz P; Nassiri M; Viciana AL; Padmanabhan J; Streilein JW
    J Immunol; 1995 Jan; 154(2):633-43. PubMed ID: 7814872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal transplantation tolerance is associated with a systemic reduction in memory cells, altered chimeric cell phenotype, and modified eicosanoid and cytokine production.
    Ruiz P; Nassiri M; Gregorian S; Viciana AL; Streilein JW
    Transplantation; 1996 Apr; 61(8):1198-205. PubMed ID: 8610418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that factor-mediated suppression silences cytotoxic T cell activity.
    Matriano JA; Socarras S; Streilein JW
    J Immunol; 1994 Aug; 153(4):1505-14. PubMed ID: 7913940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific skin transplants activate allodestructive T cells in mice resistant to neonatal H-2 tolerance induction.
    Nassiri M; Viciana A; Streilein JW; Ruiz P
    Transplantation; 1993 Dec; 56(6):1460-7. PubMed ID: 8279020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that precursor cytotoxic T cells are present but silenced.
    Matriano JA; Socarras S; Streilein JW
    J Immunol; 1994 Aug; 153(4):1515-26. PubMed ID: 8046230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatally tolerant rats actively eliminate donor-specific lymphocytes despite persistent chimerism.
    Cutler AJ; Bell EB
    Eur J Immunol; 1996 Feb; 26(2):320-8. PubMed ID: 8617298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of I-E expression on induction of neonatal transplantation tolerance.
    Streilein JW; Socarras S; Powell TJ
    Eur J Immunol; 1991 Feb; 21(2):261-6. PubMed ID: 1999218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of neonatal transplantation tolerance.
    Streilein JW; Mohler K; Wood PJ
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):82-7. PubMed ID: 2962357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells.
    Powell TJ; Streilein JW
    J Immunol; 1990 Feb; 144(3):854-9. PubMed ID: 2136901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
    Tomita Y; Khan A; Sykes M
    J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes.
    Mohler KM; Streilein JW
    J Immunol; 1987 Oct; 139(7):2211-9. PubMed ID: 2958541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in mice.
    Jánossy T; Baranyi L; Knulst AC; Vizler C; Benner R; Kelényi G; Végh P
    Eur J Immunol; 1993 Nov; 23(11):3011-20. PubMed ID: 8223878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cytotoxic cells in mice rendered neonatally tolerant of MHC alloantigens: evidence for repertoire modification.
    Wood PJ; Strome PG; Streilein JW
    J Immunol; 1987 Jun; 138(11):3661-8. PubMed ID: 2884256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 Th2 cells do not functionally suppress CTL generation in neonatal tolerant mice.
    Gao Q; Chen N; Field EH
    Transplantation; 1995 Dec; 60(11):1260-8. PubMed ID: 8525520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.